FDA clears AtriCure's heart device

06/14/2010 | MedCityNews.com

AtriCure has received 510(k) clearance from the FDA for its AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion System, which prevents blood clots during cardiac procedures. The company plans a full launch of the product this year.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care